457 related articles for article (PubMed ID: 16855314)
1. Antibiotic resistance of Salmonella enterica serovar Paratyphi A in India: emerging and reemerging problem.
Mandal S; Mandal MD; Pal NK
J Postgrad Med; 2006; 52(3):163-6. PubMed ID: 16855314
[TBL] [Abstract][Full Text] [Related]
2. Changing trends in antimicrobial resistance of Salmonella enterica serovar typhi and salmonella enterica serovar paratyphi A in Chennai.
Krishnan P; Stalin M; Balasubramanian S
Indian J Pathol Microbiol; 2009; 52(4):505-8. PubMed ID: 19805957
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
[TBL] [Abstract][Full Text] [Related]
4. Emerging Salmonella Paratyphi A enteric fever and changing trends in antimicrobial resistance pattern of salmonella in Shimla.
Verma S; Thakur S; Kanga A; Singh G; Gupta P
Indian J Med Microbiol; 2010; 28(1):51-3. PubMed ID: 20061765
[TBL] [Abstract][Full Text] [Related]
5. Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives.
Pokharel BM; Koirala J; Dahal RK; Mishra SK; Khadga PK; Tuladhar NR
Int J Infect Dis; 2006 Nov; 10(6):434-8. PubMed ID: 16978898
[TBL] [Abstract][Full Text] [Related]
6. Increase in minimum inhibitory concentration to quinolones and ceftriaxone in salmonellae causing enteric fever.
Sekar U; Srikanth P; Kindo AJ; Babu VP; Ramasubramanian V
J Commun Dis; 2003 Sep; 35(3):162-9. PubMed ID: 15796408
[TBL] [Abstract][Full Text] [Related]
7. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
[TBL] [Abstract][Full Text] [Related]
8. An increase in enteric fever cases due to Salmonella Paratyphi A in & around Chandigarh.
Gupta V; Kaur J; Chander J
Indian J Med Res; 2009 Jan; 129(1):95-8. PubMed ID: 19287065
[TBL] [Abstract][Full Text] [Related]
9. Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia.
Hassing RJ; Menezes GA; van Pelt W; Petit PL; van Genderen PJ; Goessens WH
Int J Antimicrob Agents; 2011 Mar; 37(3):240-3. PubMed ID: 21227657
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi.
Jain S; Das Chugh T
J Infect Dev Ctries; 2013 Nov; 7(11):788-95. PubMed ID: 24240035
[TBL] [Abstract][Full Text] [Related]
11. Etiological agents of bacteraemia and antibiotic susceptibility pattern in Kathmandu Model Hospital.
Amatya NM; Shrestha B; Lekhak B
JNMA J Nepal Med Assoc; 2007; 46(167):112-8. PubMed ID: 18274566
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of typhoid and paratyphoid fever in Kathmandu: two years study and trends of antimicrobial resistance.
Malla S; Kansakar P; Serichantalergs O; Rahman M; Basnet S
JNMA J Nepal Med Assoc; 2005; 44(157):18-22. PubMed ID: 16082406
[TBL] [Abstract][Full Text] [Related]
13. Absence of multidrug resistance in Salmonella enterica serotypes Typhi and Paratyphi A isolates with intermediate susceptibility to ciprofloxacin.
Misra R; Prasad KN; Amrin N; Kapoor P; Singh S; Ghar M
Trans R Soc Trop Med Hyg; 2015 Aug; 109(8):538-40. PubMed ID: 25979527
[TBL] [Abstract][Full Text] [Related]
14. Emergence of multidrug-resistant Salmonella enterica serovar Typhi associated with a class 1 integron carrying the dfrA7 gene cassette in Nepal.
Tamang MD; Oh JY; Seol SY; Kang HY; Lee JC; Lee YC; Cho DT; Kim J
Int J Antimicrob Agents; 2007 Oct; 30(4):330-5. PubMed ID: 17629465
[TBL] [Abstract][Full Text] [Related]
15. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003.
Shirakawa T; Acharya B; Kinoshita S; Kumagai S; Gotoh A; Kawabata M
Diagn Microbiol Infect Dis; 2006 Apr; 54(4):299-303. PubMed ID: 16466897
[TBL] [Abstract][Full Text] [Related]
16. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes typhi and paratyphi A isolated from the Infectious Diseases Hospital, Kuwait.
Dimitrov T; Dashti AA; Albaksami O; Jadaon MM
J Clin Pathol; 2010 Jan; 63(1):83-7. PubMed ID: 19889623
[TBL] [Abstract][Full Text] [Related]
17. Salmonella enterica serovar Paratyphi A and S. enterica serovar Typhi cause indistinguishable clinical syndromes in Kathmandu, Nepal.
Maskey AP; Day JN; Phung QT; Thwaites GE; Campbell JI; Zimmerman M; Farrar JJ; Basnyat B
Clin Infect Dis; 2006 May; 42(9):1247-53. PubMed ID: 16586383
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of Salmonella enterica serovars in a tertiary care hospital in southern India.
Choudhary A; Gopalakrishnan R; Nambi PS; Ramasubramanian V; Ghafur KA; Thirunarayan MA
Indian J Med Res; 2013 Apr; 137(4):800-2. PubMed ID: 23703350
[TBL] [Abstract][Full Text] [Related]
19. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid salmonellae.
Butt T; Khan MY; Ahmad RN; Salman M; Afzal RK
J Coll Physicians Surg Pak; 2006 Jan; 16(1):31-4. PubMed ID: 16441985
[TBL] [Abstract][Full Text] [Related]
20. Reduced susceptibility to ciprofloxacin and gyra gene mutation in North Indian strains of Salmonella enterica serotype Typhi and serotype Paratyphi A.
Renuka K; Kapil A; Kabra SK; Wig N; Das BK; Prasad VV; Chaudhry R; Seth P
Microb Drug Resist; 2004; 10(2):146-53. PubMed ID: 15256030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
